Gastrointestinal Cancer

Low-Dose Aspirin Reduced Risk of HCC in Patients With HBV or HCV

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date April 7, 2020

In a registry study, patients with HBV or HCV who began low-dose aspirin had lower rates of HCC and 10-year liver-related mortality compared with nonusers.

Adding Cetuximab to Chemotherapy Shortens Survival by 2 Years in Advanced CRC

By

Christina Bennett, MS

Publish Date March 30, 2020

Adding cetuximab to chemotherapy led to worse outcomes for patients with resectable liver metastases caused by colorectal cancer, updated data from the New EPOC trial showed.

Disease-Related Characteristics and Asbestos Exposure in Women With Mesothelioma

By

Susan Moench, PhD, PA-C

Publish Date March 6, 2020

In this study, the most common form of the malignant diffuse mesothelioma in women was characterized by pleural location and epitheliolid histology.

More Support for “Watch-and-Wait” Approach in Subgroup of Patients With Resectable Rectal Cancer

By

Susan Moench, PhD, PA-C

Publish Date March 5, 2020

Suspected local disease regrowth was seen in 23% of patients with rectal cancer observed following a near or complete clinical response to neoadjuvant therapy.

Risk of Therapy-Associated Polyposis Increased in Pediatric and Young Adult Cancer Survivors

By

Susan Moench, PhD, PA-C

Publish Date March 2, 2020

These findings have implications for the screening of survivors of childhood or young adult-related cancers that are independent of prior abdominopelvic radiation therapy.